Return On Equity of Ovid Therapeutics Inc. from 30 Sep 2017 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Ovid Therapeutics Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2017 to 30 Sep 2025.
  • Ovid Therapeutics Inc. Return On Equity for the quarter ending 30 Sep 2025 was -64%, a 62% decline year-over-year.
  • Ovid Therapeutics Inc. annual Return On Equity for 2024 was -34%, a 32% increase from 2023.
  • Ovid Therapeutics Inc. annual Return On Equity for 2023 was -50%, a 36% decline from 2022.
  • Ovid Therapeutics Inc. annual Return On Equity for 2022 was -37%, a 160% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Ovid Therapeutics Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -64% -24% -62% 01 Jul 2025 30 Sep 2025
Q2 2025 -59% -25% -76% 01 Apr 2025 30 Jun 2025
Q1 2025 -34% +19% +36% 01 Jan 2025 31 Mar 2025
Q4 2024 -34% +16% +32% 01 Oct 2024 31 Dec 2024
Q3 2024 -39% +2.5% +5.9% 01 Jul 2024 30 Sep 2024
Q2 2024 -33% +5.5% +14% 01 Apr 2024 30 Jun 2024
Q1 2024 -54% -16% -43% 01 Jan 2024 31 Mar 2024
Q4 2023 -50% -13% -36% 01 Oct 2023 31 Dec 2023
Q3 2023 -42% +1.3% +3% 01 Jul 2023 30 Sep 2023
Q2 2023 -39% +0.32% +0.82% 01 Apr 2023 30 Jun 2023
Q1 2023 -38% -0.55% -1.5% 01 Jan 2023 31 Mar 2023
Q4 2022 -37% -98% -160% 01 Oct 2022 31 Dec 2022
Q3 2022 -43% -119% -157% 01 Jul 2022 30 Sep 2022
Q2 2022 -39% -130% -143% 01 Apr 2022 30 Jun 2022
Q1 2022 -37% -165% -129% 01 Jan 2022 31 Mar 2022
Q4 2021 61% +232% 01 Oct 2021 31 Dec 2021
Q3 2021 76% +217% 01 Jul 2021 30 Sep 2021
Q2 2021 91% +258% 01 Apr 2021 30 Jun 2021
Q1 2021 128% +264% 01 Jan 2021 31 Mar 2021
Q4 2020 -171% -52% -44% 01 Oct 2020 31 Dec 2020
Q3 2020 -141% -9.5% -7.2% 01 Jul 2020 30 Sep 2020
Q2 2020 -167% -57% -52% 01 Apr 2020 30 Jun 2020
Q1 2020 -135% -34% -33% 01 Jan 2020 31 Mar 2020
Q4 2019 -119% -26% -27% 01 Oct 2019 31 Dec 2019
Q3 2019 -132% -56% -75% 01 Jul 2019 30 Sep 2019
Q2 2019 -110% -50% -84% 01 Apr 2019 30 Jun 2019
Q1 2019 -102% -51% -103% 01 Jan 2019 31 Mar 2019
Q4 2018 -94% -13% -16% 01 Oct 2018 31 Dec 2018
Q3 2018 -75% +11% +13% 01 Jul 2018 30 Sep 2018
Q2 2018 -60% 01 Apr 2018 30 Jun 2018
Q1 2018 -50% 01 Jan 2018 31 Mar 2018
Q4 2017 -81% 01 Oct 2017 31 Dec 2017
Q3 2017 -86% 01 Jul 2017 30 Sep 2017

Ovid Therapeutics Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -34% +16% +32% 01 Jan 2024 31 Dec 2024
2023 -50% -13% -36% 01 Jan 2023 31 Dec 2023
2022 -37% -98% -160% 01 Jan 2022 31 Dec 2022
2021 61% +232% 01 Jan 2021 31 Dec 2021
2020 -171% -52% -44% 01 Jan 2020 31 Dec 2020
2019 -119% -26% -27% 01 Jan 2019 31 Dec 2019
2018 -94% -13% -16% 01 Jan 2018 31 Dec 2018
2017 -81% 01 Jan 2017 31 Dec 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.